FABP3 and Parkinsonism: The αSyn cytotoxicity and the resultant Parkinsonism was antagonized in Fabp3−/− mice, by treatment with a competitive inhibitor of LC-PUFAs binding to FABP3 [33,35,36,37]; however, it remains unclear whether FABP3 is also related to αSyn-induced cognitive impairment and septal αSyn pathology.